MD/PhD Program, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Biol Blood Marrow Transplant. 2011 May;17(5):608-19. doi: 10.1016/j.bbmt.2010.12.697. Epub 2010 Dec 19.
Attempts to reduce the toxicity of hematopoietic stem cell transplantation have led to the use of various immunosuppressive, yet nonmyeloablative preparative regimens that often include low-dose irradiation. To determine the effects of low-dose irradiation on the dynamics of donor cell engraftment after bone marrow transplantation (BMT), we coupled standard endpoint flow cytometric analysis with in vivo longitudinal bioluminescence imaging performed throughout the early (<10 days) and late (days 10-90) post-BMT periods. To exclude the contribution of irradiation on reducing immunologic rejection, severely immune-deficient mice were chosen as recipients of allogeneic bone marrow. Flow cytometric analysis showed that sublethal doses of total body irradiation (TBI) significantly increased long-term (14 weeks) donor chimerism in the bone marrow compared with nonirradiated recipients (P < .05). Bioluminescence imaging demonstrated that the effect of TBI (P < .001) on chimerism occurred only after the first 7 days post-BMT. Flow cytometric analysis on day 3 showed no increase in the number of donor cells in irradiated bone marrow, confirming that sublethal irradiation does not enhance marrow chimerism early after transplantation. Local irradiation also significantly increased late (but not early) donor chimerism in the irradiated limb. Intrafemoral injection of donor cells provided efficient early chimerism in the injected limb, but long-term systemic donor chimerism was highest with i.v. administration (P < .05). Overall, the combination of TBI and i.v. administration of donor cells provided the highest levels of long-term donor chimerism in the marrow space. These findings suggest that the major effect of sublethal irradiation is to enhance long-term donor chimerism by inducing proliferative signals after the initial phase of homing.
为了降低造血干细胞移植的毒性,人们尝试采用各种免疫抑制但非清髓性的预处理方案,其中常常包括低剂量照射。为了确定低剂量照射对骨髓移植(BMT)后供体细胞植入动力学的影响,我们将标准终点流式细胞术分析与整个早期(<10 天)和晚期(第 10-90 天)BMT 期间进行的体内纵向生物发光成像相结合。为了排除照射对减少免疫排斥的贡献,我们选择严重免疫缺陷的小鼠作为异基因骨髓的受体。流式细胞术分析显示,亚致死剂量的全身照射(TBI)与未照射受体相比,显著增加了骨髓中的长期(14 周)供体细胞嵌合率(P <.05)。生物发光成像显示,TBI(P <.001)对嵌合率的影响仅发生在 BMT 后第 1 天。第 3 天的流式细胞术分析显示,照射骨髓中供体细胞数量没有增加,证实亚致死照射在移植后早期不会增强骨髓嵌合率。局部照射也显著增加了照射肢体的晚期(但不是早期)供体细胞嵌合率。供体细胞的股骨内注射在注射肢体中提供了有效的早期嵌合率,但静脉内给药的长期系统供体细胞嵌合率最高(P <.05)。总体而言,TBI 与静脉内给予供体细胞的组合在骨髓空间中提供了最高水平的长期供体细胞嵌合率。这些发现表明,亚致死照射的主要作用是通过诱导归巢初始阶段后的增殖信号来增强长期供体细胞嵌合率。